secwatch.observer — SEC 8-K summary
======================================

Issuer:     CODEXIS, INC. (CDXS)
CIK:        0001200375
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-269716
Event type: leadership
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 2.05, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Codexis appoints Alison Moore CEO, cuts 24% workforce, signs $37.8M Merck deal; Q3 net loss $19.6M
--------------------------------------------------------------------------------

- Alison Moore appointed President and CEO effective Nov 7, 2025; Stephen Dilly becomes Executive Chairman.
- Workforce reduced by 46 positions (~24%); expects $3.5M expense in Q4 2025, substantially completed by Jan 2026.
- Signed $37.8M Supply Assurance Agreement with Merck; cash anticipated by year-end 2025.
- Q3 2025 revenue $8.6M (down from $12.8M YoY); net loss $19.6M ($0.22/share).
- Cash and investments $58.7M as of Sept 30, 2025; cash runway extended through 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1200375/000119312525269716/0001193125-25-269716-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1200375/000119312525269716/d80118d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-269716

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer